NCT06928506View on ClinicalTrials.gov

Effect of Hi-OxSR for the Treatment of Post COVID Condition

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Long COVIDPost COVID-19 ConditionPost Acute Sequelae of COVID-19
Interventions
DEVICE

Hi-OxSR device

The Hi-OxSR device consists of the Hi-Ox mask connected to a portable oxygen concentrator, with added tubing serving as a reservoir for rebreathed exhaled breath.

DEVICE

Hi-Ox device

The Hi-Ox mask is connected to a portable oxygen concentrator.

Trial Locations (3)

Unknown

NOT_YET_RECRUITING

Kaye Edmonton Clinic, Edmonton

NOT_YET_RECRUITING

Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke

M5G 2C4

RECRUITING

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER